Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.

Abstract

To evaluate the efficacy of systemic ifosfamide, cisplatin (CDDP) combination as first line treatment followed by intraperitoneal (IP) chemotherapy with carboplatin (CBCDA) and etoposide as consolidation in patients with stage III and IV epithelial ovarian cancer. A total of 40 patients with stage III and IV ovarian cancer were entered into the study… (More)

Topics

Cite this paper

@article{Aziz1998PhaseIT, title={Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.}, author={Zeba Aziz and Mohammad Ahmad Zahid and Z Ud Din Ahmed and Tania Arshad}, journal={Australian and New Zealand journal of medicine}, year={1998}, volume={28 3}, pages={403-9} }